Cargando…

Therapeutic potential of medicinal marijuana: an educational primer for health care professionals

With the proposed Canadian July 2018 legalization of marijuana through the Cannabis Act, a thorough critical analysis of the current trials on the efficacy of medicinal marijuana (MM) as a treatment option is necessary. This review is particularly important for primary care physicians whose patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouhamed, Yara, Vishnyakov, Andrey, Qorri, Bessi, Sambi, Manpreet, Frank, SM Signy, Nowierski, Catherine, Lamba, Anmol, Bhatti, Umrao, Szewczuk, Myron R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001746/
https://www.ncbi.nlm.nih.gov/pubmed/29928146
http://dx.doi.org/10.2147/DHPS.S158592
_version_ 1783332072092336128
author Mouhamed, Yara
Vishnyakov, Andrey
Qorri, Bessi
Sambi, Manpreet
Frank, SM Signy
Nowierski, Catherine
Lamba, Anmol
Bhatti, Umrao
Szewczuk, Myron R
author_facet Mouhamed, Yara
Vishnyakov, Andrey
Qorri, Bessi
Sambi, Manpreet
Frank, SM Signy
Nowierski, Catherine
Lamba, Anmol
Bhatti, Umrao
Szewczuk, Myron R
author_sort Mouhamed, Yara
collection PubMed
description With the proposed Canadian July 2018 legalization of marijuana through the Cannabis Act, a thorough critical analysis of the current trials on the efficacy of medicinal marijuana (MM) as a treatment option is necessary. This review is particularly important for primary care physicians whose patients may be interested in using MM as an alternative therapy. In response to increased interest in MM, Health Canada released a document in 2013 for general practitioners (GPs) as an educational tool on the efficacy of MM in treating some chronic and acute conditions. Although additional studies have filled in some of the gaps since the release of the Health Canada document, conflicting and inconclusive results continue to pose a challenge for physicians. This review aims to supplement the Health Canada document by providing physicians with a critical yet concise update on the recent advancements made regarding the efficacy of MM as a potential therapeutic option. An update to the literature of 2013 is important given the upcoming changes in legislation on the use of marijuana. Also, we briefly highlight the current recommendations provided by Canadian medical colleges on the parameters that need to be considered prior to authorizing MM use, routes of administration as well as a general overview of the endocannabinoid system as it pertains to cannabis. Lastly, we outline the appropriate medical conditions for which the authorization of MM may present as a practical alternative option in improving patient outcomes as well as individual considerations of which GPs should be mindful. The purpose of this paper is to offer physicians an educational tool that provides a necessary, evidence-based analysis of the therapeutic potential of MM and to ensure physicians are making decisions on the therapeutic use of MM in good faith.
format Online
Article
Text
id pubmed-6001746
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-60017462018-06-20 Therapeutic potential of medicinal marijuana: an educational primer for health care professionals Mouhamed, Yara Vishnyakov, Andrey Qorri, Bessi Sambi, Manpreet Frank, SM Signy Nowierski, Catherine Lamba, Anmol Bhatti, Umrao Szewczuk, Myron R Drug Healthc Patient Saf Review With the proposed Canadian July 2018 legalization of marijuana through the Cannabis Act, a thorough critical analysis of the current trials on the efficacy of medicinal marijuana (MM) as a treatment option is necessary. This review is particularly important for primary care physicians whose patients may be interested in using MM as an alternative therapy. In response to increased interest in MM, Health Canada released a document in 2013 for general practitioners (GPs) as an educational tool on the efficacy of MM in treating some chronic and acute conditions. Although additional studies have filled in some of the gaps since the release of the Health Canada document, conflicting and inconclusive results continue to pose a challenge for physicians. This review aims to supplement the Health Canada document by providing physicians with a critical yet concise update on the recent advancements made regarding the efficacy of MM as a potential therapeutic option. An update to the literature of 2013 is important given the upcoming changes in legislation on the use of marijuana. Also, we briefly highlight the current recommendations provided by Canadian medical colleges on the parameters that need to be considered prior to authorizing MM use, routes of administration as well as a general overview of the endocannabinoid system as it pertains to cannabis. Lastly, we outline the appropriate medical conditions for which the authorization of MM may present as a practical alternative option in improving patient outcomes as well as individual considerations of which GPs should be mindful. The purpose of this paper is to offer physicians an educational tool that provides a necessary, evidence-based analysis of the therapeutic potential of MM and to ensure physicians are making decisions on the therapeutic use of MM in good faith. Dove Medical Press 2018-06-11 /pmc/articles/PMC6001746/ /pubmed/29928146 http://dx.doi.org/10.2147/DHPS.S158592 Text en © 2018 Mouhamed et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Mouhamed, Yara
Vishnyakov, Andrey
Qorri, Bessi
Sambi, Manpreet
Frank, SM Signy
Nowierski, Catherine
Lamba, Anmol
Bhatti, Umrao
Szewczuk, Myron R
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
title Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
title_full Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
title_fullStr Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
title_full_unstemmed Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
title_short Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
title_sort therapeutic potential of medicinal marijuana: an educational primer for health care professionals
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001746/
https://www.ncbi.nlm.nih.gov/pubmed/29928146
http://dx.doi.org/10.2147/DHPS.S158592
work_keys_str_mv AT mouhamedyara therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT vishnyakovandrey therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT qorribessi therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT sambimanpreet therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT franksmsigny therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT nowierskicatherine therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT lambaanmol therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT bhattiumrao therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT szewczukmyronr therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals